Ching-Lan Cheng

Personal profile

Education

2010 PhD, Institute of Clinical Pharnacy and Pharmaceutical Sciences, National Cheng Kung University

Experience

20017/1-present Vice Director, Department of Pharmacy, National Cheng Kung University Hospital
2012/8~present Assistant professor, School of Pharmacy, National Cheng Kung University

Research Interests

Clinical pharmacy
Parmacoepidemiology

Fingerprint Dive into the research topics where Ching-Lan Cheng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

37 Similar Profiles

Taiwan Medicine & Life Sciences

National Health Programs Medicine & Life Sciences

Venous Thromboembolism Medicine & Life Sciences

Databases Medicine & Life Sciences

Hydroxymethylglutaryl-CoA Reductase Inhibitors Medicine & Life Sciences

clopidogrel Medicine & Life Sciences

Stroke Medicine & Life Sciences

Prescriptions Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

台灣抗生素之抗藥性、處方型態及療效於新生兒及孩童多中心聯合資訊

Cheng, C.

17-08-01 → 18-07-31

Project: Research project

全球抗生素之抗藥性、處方型態及療效於新生兒及孩童多國聯合資訊-建立台灣前導模式

Cheng, C.

16-08-01 → 17-07-31

Project: Research project

小兒使用氟?諾酮類抗生素之安全性評估

Cheng, C.

14-08-01 → 15-07-31

Project: Research project

低體重兒使用類固醇與神經發展障礙相關性之藥物流行病學研究

Cheng, C.

13-08-01 → 14-07-31

Project: Research project

Research Output 2005 2019

1702 Citations
16 h-Index
33 Article
1 Letter

7 Citations (Scopus)

Detecting potential adverse drug reactions using a deep neural network model

Wang, C. S., Lin, P. J., Cheng, C-L., Tai, S. H., Kao, Y-H. & Chiang, J-H., 2019 Feb 1, In : Journal of medical Internet research. 21, 2, e11016.

Research output: Contribution to journal › Article

Neural Networks (Computer)

Drug-Related Side Effects and Adverse Reactions

Pharmaceutical Preparations

Pharmacovigilance

ROC Curve

14 Citations (Scopus)

Cardiovascular and bleeding risks in acute myocardial infarction newly treated with ticagrelor vs. Clopidogrel in Taiwan

Lee, C. H., Cheng, C. L., Kao Yang, Y. H., Chao, T. H., Chen, J. Y. & Li, Y. H., 2018 Jan 1, In : Circulation Journal. 82, 3, p. 747-756 10 p.

Research output: Contribution to journal › Article

clopidogrel

Taiwan

Myocardial Infarction

Hemorrhage

Safety

1 Citation (Scopus)

Pay for performance program reduces treatment needed diabetic retinopathy - A nationwide matched cohort study in Taiwan

Sheu, S. J., Lin, W. L., Kao, Y-H., Hwu, C. M. & Cheng, C-L., 2018 Aug 15, In : BMC Health Services Research. 18, 1, 638.

Research output: Contribution to journal › Article

Incentive Reimbursement

Diabetic Retinopathy

Taiwan

Cohort Studies

Therapeutics

5 Citations (Scopus)

Mortality prediction using CHADS₂ /CHA₂ DS₂ -VASc/R₂ CHADS₂ scores in systolic heart failure patients with or without atrial fibrillation

Chen, Y. L., Cheng, C. L., Huang, J. L., Yang, N. I., Chang, H. C., Chang, K. C., Sung, S. H., Shyu, K. G., Wang, C. C., Yin, W. H., Lin, J. L. & Chen, S. M., 2017 Oct 1, In : Medicine (United States). 96, 43, e8338.

Research output: Contribution to journal › Article

Systolic Heart Failure

Atrial Fibrillation

Mortality

Taiwan

Cardiology